| NDC Code | 82797-129-12 |
| Package Description | 120 mL in 1 BOTTLE, PLASTIC (82797-129-12) |
| Product NDC | 82797-129 |
| Product Type Name | HUMAN OTC DRUG |
| Proprietary Name | Alfalfa Plus Ginseng Syrup |
| Non-Proprietary Name | Alfalfa, China Off, Avena Sativa, Hydrastis Can, Ginseng, Ferric Citrate, Nat Phos, Mag Phos, Calc Phos, Kali Phos, Ferr Phos, |
| Dosage Form | SYRUP |
| Usage | ORAL |
| Start Marketing Date | 20240704 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Manufacturer | Dr. Masood Homeopathic Pharmaceuticals Private Limited |
| Substance Name | ALFALFA; AVENA SATIVA WHOLE; CALCIUM PHOSPHATE; CINCHONA OFFICINALIS WHOLE; DIBASIC POTASSIUM PHOSPHATE; FERRIC CITRATE ANHYDROUS; FERROUS SULFATE; HYDRASTIS CANADENSIS WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PANAX GINSENG WHOLE; SODIUM PHOSPHATE |
| Strength | 4.32; 2.4; .48; 3.84; .48; 3; .48; 1.44; .48; 2.16; .48 |
| Strength Unit | mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL; mg/120mL |
| Pharmacy Classes | Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Iron [CS], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |